EBE announces its 2018-2020 Board of Directors
Brussels, 2 July 2018 – The European Biopharmaceutical Enterprises (EBE), is pleased to announce its Board of Directors for 2018-2020, following the decisions taken at the EBE Annual Meeting on 26 June 2018. EBE has appointed a new president, Ahmed Bouzidi and a new vice-president, François Martelet. Dr Bouzidi has been a board member of EBE